President-elect Trump has nominated biotech investor Jim O’Neill for deputy secretary of the Health and Human Services ...

President-elect Trump has chosen Stanford University professor Jay Bhattacharya to lead the National Institutes of Health, ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

LONDON — Policymakers and scientific groups need to specify guidelines for the burgeoning field that uses stem cells to mimic ...

Health officials in British Columbia, Canada, have failed, for now, to confirm how a teenager there became infected with H5N1 ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Marty Makary, a Johns Hopkins surgeon and outspoken critic of parts of the U.S. medical system, is Trump’s pick for FDA ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

The Biden administration is proposing changes to Medicare Advantage plans designed to alleviate coverage barriers ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of ...